Inventor · disambiguated record
Thomas Bohnacker
Also filed as: BOHNACKER THOMAS
1 granted patent·3 pending applications·0 citations·filing 2021–2022
11Inventor score
Files withTOLREMO THERAPEUTICS AG4
Top patents by PatentIndex Score
4 records- 0150US2024327394A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancerTOLREMO THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0247US12472179B2Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancerTOLREMO THERAPEUTICS AG·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 0339US2023255966A1A combination of a cbp/p300 bromodomain inhibitor and an egfr inhibitor for use in treating egfr-mutant nsclcTOLREMO THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0439US2023226057A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic diseaseTOLREMO THERAPEUTICS AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Bohnacker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →